One dose of human papillomavirus vaccine noninferior to two for preventing persistent infection
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A study has found that one dose of the human papillomavirus vaccine is noninferior to two doses for preventing persistent infection. This finding suggests that a single dose of the vaccine may be as effective as two doses. The results of the study appear to be supported by multiple health organizations and experts, although the context and implications of the finding are still being discussed.
Full coverage
1
The New England Journal of Medicine·Dec 32
National Institutes of Health (NIH) | (.gov)·Jan 133
Vaccine Advisor·Dec 104
Cleveland Clinic·Mar 45
MedPage Today·Jan 76
Gavi, the Vaccine Alliance·Jan 297MedPage Today·Dec 38
publichealth.jhu.edu·Jun 8